Cheonan-si, South Korea

Nam Song Choi




Average Co-Inventor Count = 8.4

ph-index = 3

Forward Citations = 121(Granted Patents)


Location History:

  • Seoul, KR (2000 - 2001)
  • Cheonan-si, KR (2016)

Company Filing History:


Years Active: 2000-2016

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Inventor Nam Song Choi

Introduction

Nam Song Choi is a notable inventor based in Cheonan-si, South Korea. He has made significant contributions to the field of pharmaceuticals, holding a total of four patents. His work primarily focuses on compounds that have therapeutic applications, particularly in the treatment of metabolic disorders.

Latest Patents

Among his latest patents is a compound that inhibits the 11Beta-HSD1 enzyme, which is crucial in the management of various health conditions. This invention includes a preparation method and a pharmaceutical composition that utilizes the compound as an active ingredient. The compound selectively inhibits the activity of 11β-HSD1, making it a potential therapeutic agent for diseases such as non-insulin dependent type II diabetes, insulin resistance, obesity, and metabolic syndrome. Another significant patent involves a process for preparing camptothecin derivatives, which are important in cancer treatment.

Career Highlights

Nam Song Choi has worked with prominent companies in the pharmaceutical industry, including Chong Kun Dang Corporation and Ahn-gook Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

He has collaborated with notable colleagues, including Soon Kil Ahn and Jung Woo Kim, to advance his research and development efforts.

Conclusion

Nam Song Choi's innovative work in the pharmaceutical field demonstrates his commitment to developing effective treatments for serious health conditions. His patents reflect a deep understanding of biochemistry and a dedication to improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…